Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the jetpack-backup domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/vgbdoo6u2d7y/public_html/mcmillanresearch.com/wp-includes/functions.php on line 6121
Covid Boosters - Does not knowing risk equate to having no risk? - McMillan Research Limited
Select Page

Covid Boosters – Does not knowing risk equate to having no risk?

May 7, 2024 | COVID-19, Research, Treatment

Responsive Centered YouTube Video
Vaccination impact on long covid patients and immune response discussed in recent study.

  • Vaccination associated with decrease in post-covid conditions and pro-inflammatory cytokines. • 2:57

  • Sars-Cov-2 S1 antigen found in blood of post-covid patients, regardless of vaccination status. • 3:29

  • Study conducted in late 2020-2021 showed improved symptoms in vaccinated patients. • 3:53

Understanding the potential risks of administering vaccines without knowing the mechanism of improvement.

  • Study population: 83 participants in Canada with post-COVID conditions. • 4:06

  • Participants received various vaccines with the option of one or two doses. • 5:03

  • No change in Spike protein concentration despite symptom improvement post-vaccination. • 6:51

  • Caution against assuming benefits without understanding the mechanism of improvement. • 7:21

  • Need for further research to determine the effects and risks of vaccination. • 7:33

Importance of understanding risks in decision-making regarding Covid boosters.

  • Balancing risks and benefits in vaccination discussions is crucial for informed decisions. • 7:58

  • Acknowledging unknown risks and uncertainties is essential in medical advice. • 8:27

  • Long-term risks may not be immediately apparent, emphasizing the need for ongoing evaluation. • 8:36

  • Increased levels of non-inflammatory IGG-4 antibodies post-MRNA vaccination may contribute to improved symptoms. • 10:52

  • Educating oneself on the factors influencing vaccine effectiveness is key in decision-making. • 11:32

Understanding the potential risks and benefits of IgG4 in improving symptoms of long Covid post-vaccination.

  • IgG4 may play a role in reducing symptoms of long Covid after vaccination. • 12:50

  • Elevated IgG4 levels post-vaccination may have implications on long-term immunity. • 13:33

  • Concerns about potential risks of IgG4 reducing the ability of the immune system to fight the virus. • 14:06

  • Uncertainty regarding the longevity of symptom improvement with IgG4 elevation. • 14:49

  • Consideration of temporary benefits versus unknown medium to long-term risks. • 15:06

Informed decision-making on potential risks of treatments is crucial for individuals' health.

  • Steroids may help suppress symptoms of immunemediated conditions, but long-term risks are unknown. • 15:21

  • Uncertainty exists regarding the risks of treatments like steroids and igg4. • 15:42

  • Informed consent involves understanding suggested benefits and unknown risks. • 16:51

  • Educating individuals allows them to make decisions based on personal risk assessment. • 17:14

  • Science should empower individuals to make informed decisions for themselves. • 17:23

  • Making decisions based on understanding and personal interest is key. • 17:30

  • Importance of considering risks and benefits in decision-making processes. • 17:53